Milwaukee: GLP-1 Medications and Disordered Eating: A Personalized, Evidence-Based Approach 8 May @ 9:00 am 3:00 pm This event brings together two timely and thought-provoking sessions that explore the evolving intersection of nutrition, mental health, and medical treatment in eating disorder care
Tirzepatide consists of 39 amino acids, with its N-terminal region resembling GIP and its C-terminal region similar to the GLP-1 receptor agonist exenatide [27]
94 However, NAD increases also led to reduced activation of the WNT canonical pathway
Nutrition in patients with type 2 diabetes: present knowledge and remaining challenges
NEJM (December 2025) Bottom Line: This active-comparator-controlled, double-blind, noninferiority trial evaluated tirzepatide (up to 15 mg) against dulaglutide (1.5 mg) in patients with type 2 diabetes and atherosclerotic cardiovascular disease over a study duration involving 13,299 patients
Today, we are talking about the ultimate tool for gut restoration